Literature DB >> 8484668

Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

K Lehtinen1.   

Abstract

The mortality and causes of death in 398 patients (47 women, 351 men) with definite ankylosing spondylitis, admitted to hospital for the first time between 1961 and 1969, were investigated. The mean age at first admission was 36.5 years (SD 11.8). After a mean follow up time of 25.7 years, a total of 152 patients (12 women, 140 men) had died. The expected mortality based on the mortality statistics of the general population of the same sex and age was 103.1 (9.4 women and 93.7 men). Thus the overall mortality of the patients with ankylosing spondylitis was 1.5 times that expected. Those patients who had died were significantly older, had a higher erythrocyte sedimentation rate, and more inflamed peripheral joints when first seen than the surviving patients. The main difference between the observed and expected causes of death was the high incidence of deaths from ankylosing spondylitis, which was the underlying cause of death in 27 patients. The mechanism of death in these patients was secondary amyloidosis in 19, cardiovascular complications in six, fracture of the spine in one, and it was not known in one patient. Excess deaths due to circulatory, gastrointestinal and renal diseases, and violence were also observed.

Entities:  

Mesh:

Year:  1993        PMID: 8484668      PMCID: PMC1005012          DOI: 10.1136/ard.52.3.174

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  14 in total

1.  Pathology of ankylosing spondylitis.

Authors:  B CRUICKSHANK
Journal:  Bull Rheum Dis       Date:  1960-03

2.  Mortality among patients with ankylosing spondylitis not given X-ray therapy.

Authors:  E P Radford; R Doll; P G Smith
Journal:  N Engl J Med       Date:  1977-09-15       Impact factor: 91.245

3.  Ankylosing spondylitis.

Authors:  F D Hart
Journal:  Lancet       Date:  1968-12-21       Impact factor: 79.321

4.  Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis.

Authors:  W M Brown; R Doll
Journal:  Br Med J       Date:  1965-12-04

5.  Amyloidosis in ankylosing spondylitis.

Authors:  M I Jayson; P R Salmon; W Harrison
Journal:  Rheumatol Phys Med       Date:  1971-05

6.  [Ankylosing spondylarthritis and amyloidosis].

Authors:  J Villiaumey; E Lejeune; B Avouac; P Horreard
Journal:  Ann Med Interne (Paris)       Date:  1978-01

7.  Cause of death in 79 patients with ankylosing spondylitis.

Authors:  K Lehtinen
Journal:  Scand J Rheumatol       Date:  1980       Impact factor: 3.641

8.  Epidemiology of Ankylosing spondylitis in Rochester, Minnesota, 1935-1973.

Authors:  E T Carter; C H McKenna; D D Brian; L T Kurland
Journal:  Arthritis Rheum       Date:  1979-04

9.  Survival among patients with ankylosing spondylitis: a life-table analysis.

Authors:  M A Khan; M K Khan; I Kushner
Journal:  J Rheumatol       Date:  1981 Jan-Feb       Impact factor: 4.666

10.  Mortality among patients with ankylosing spondylitis after a single treatment course with x rays.

Authors:  P G Smith; R Doll
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-13
View more
  56 in total

1.  How to diagnose axial spondyloarthropathy early.

Authors:  N Barkham; H Marzo-Ortega; D McGonagle; P Emery
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

2.  Spectrum of ankylosing spondylitis in Portugal. Development of BASDAI, BASFI, BASMI and mSASSS reference centile charts.

Authors:  Fernando M Pimentel-Santos; Ana Filipa Mourão; Célia Ribeiro; José Costa; Helena Santos; Anabela Barcelos; Patricia Pinto; Fátima Godinho; Margarida Cruz; Elsa Vieira-Sousa; Rui André Santos; Sara Rabiais; Jorge Félix; João Eurico Fonseca; Henrique Guedes-Pinto; Matthew A Brown; Jaime C Branco
Journal:  Clin Rheumatol       Date:  2011-10-19       Impact factor: 2.980

3.  Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.

Authors:  V P van Halm; J C van Denderen; M J L Peters; J W R Twisk; M van der Paardt; I E van der Horst-Bruinsma; R J van de Stadt; M H M T de Koning; B A C Dijkmans; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2006-04-27       Impact factor: 19.103

Review 4.  Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports.

Authors:  E S Strobel; E Fritschka
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 5.  Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis.

Authors:  V F Azevedo; R Pecoits-Filho
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

Review 6.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

7.  Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; R Landewé; H Schouten; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 8.  Expanding the armamentarium for the spondyloarthropathies.

Authors:  Paul M Peloso; Jürgen Braun
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156

9.  Serum homocysteine level in patients with ankylosing spondylitis.

Authors:  Bedriye Mermerci Başkan; Filiz Sivas; Lale Akbulut Aktekin; Yasemin Pekin Doğan; Kürşat Ozoran; Hatice Bodur
Journal:  Rheumatol Int       Date:  2009-03-15       Impact factor: 2.631

10.  Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: a report from the Australian rheumatology association database.

Authors:  John Oldroyd; Lionel Schachna; Rachelle Buchbinder; Margaret Staples; Bridie Murphy; Molly Bond; Andrew Briggs; Marissa Lassere; Lyn March
Journal:  Int J Rheumatol       Date:  2009-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.